Hatteras BioCapital

Overview

Hatteras BioCapital is an investment advisory firm specializing in clinical stage life science companies. The firm serves as the General Partner of the Hatteras BioCapital Fund, LP, a single-purpose entity designed to invest in later-stage, product-focused life science funds. Their investment strategy encompasses early-stage, growth, and late-stage investments, primarily within the United States. The firm focuses on a wide array of industries, including biotechnology, healthcare, pharmaceuticals, medical devices, diagnostics, and various life sciences sectors. Hatteras BioCapital's investment philosophy emphasizes a thorough and principled approach, aiming to build transformational companies that benefit patients and the professionals who serve them. They actively partner with visionary founders to cultivate optionality and identify value, leveraging their deep, multi-disciplinary expertise to invest broadly across the healthcare space. Their track record includes over 25 years of experience and more than 100 companies, demonstrating their commitment to advancing human medicine through strategic investments.

Investment Focus

• Clinical stage life science companies
• Innovative technologies
• Strong management teams
• Potential for significant patient impact
• Alignment with firm's investment strategy

Portfolio Companies